A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.

Fabian Hammer, Uwe Malzahn, Julian Donhauser, Christoph Betz, Markus Schneider (Co-author), Clemens Grupp, Nils Pollak, Stefan Störk, Christoph Wanner, Vera Krane

    Research output: Contribution to journalOriginal Article (Journal)peer-review

    59 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)983-991
    JournalKIDNEY INTERNATIONAL
    Volume95
    Issue number4
    DOIs
    Publication statusPublished - 2019

    Keywords

    • MINERALOCORTICOID RECEPTOR ANTAGONISTS
    • CHRONIC KIDNEY-DISEASE
    • SUDDEN CARDIAC DEATH
    • STAGE RENAL-DISEASE
    • DIALYSIS PATIENTS
    • HEART-FAILURE
    • DOUBLE-BLIND
    • FOLLOW-UP
    • HYPERTROPHY
    • EPLERENONE

    Cite this